ALNY vs QUMSR
Alnylam Pharmaceuticals Inc (ALNY) versus Quantumsphere Acquisition Corp. Rights (QUMSR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Quantumsphere Acquisition Corp. Rights (QUMSR) common stock listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
QUMSR does not have a complete income-statement cache yet.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. QUMSR currently screens at market cap $0.
Not investment advice. Open the ALNY and QUMSR stock pages for the full models.
Not investment advice.